We are live on
!
Find out more
Ninety One (UK) Portfolio holdings
AUM
$44.7B
1-Year Est. Return
17.24%
This Fund
S&P 500
This Quarter
Est. Return
+2.88%
1 Year Est. Return
+17.24%
3 Year Est. Return
+87.79%
5 Year Est. Return
+111.34%
10 Year Est. Return
+534.1%
AUM
$18.5B
AUM Growth
+$969M
(+5.5%)
Cap. Flow
+$640M
Cap. Flow
% of AUM
3.46%
Top 10 Holdings %
Top 10 Hldgs %
19.12%
Holding
358
New
39
Increased
130
Reduced
123
Closed
55
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$275M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$218M |
| 3 |
Johnson & Johnson
JNJ
|
+$172M |
| 4 |
CME Group
CME
|
+$140M |
| 5 |
Lam Research
LRCX
|
+$127M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Goldman Sachs
GS
|
+$236M |
| 2 |
STJ
St Jude Medical
STJ
|
+$176M |
| 3 |
Moody's
MCO
|
+$173M |
| 4 |
Bausch Health
BHC
|
+$134M |
| 5 |
Marathon Petroleum
MPC
|
+$117M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.72% |
| 2 | Healthcare | 18.05% |
| 3 | Financials | 17.97% |
| 4 | Communication Services | 9.14% |
| 5 | Consumer Staples | 8.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Medtronic
MDT
$105B
| $205M | 1.11% |
2,734,299
+108,233
| +4% | +$8.15M |
|
27
eBay
EBAY
$48.5B
| $198M | 1.07% |
8,316,723
+404,945
| +5% | +$9.85M |
|
|
FISV
28
Fiserv Inc
FISV
$26.6B
| $198M | 1.07% |
3,857,222
+219,946
| +6% | +$10.4M |
|
29
Amdocs
DOX
$5.4B
| $198M | 1.07% |
3,269,460
+150,828
| +5% | +$8.45M |
|
30
NetEase
NTES
$76.9B
| $193M | 1.05% |
6,734,415
-1,382,670
| -17% | -$41.4M |
|
31
Cigna
CI
$75.7B
| $188M | 1.01% |
1,367,245
+65,343
| +5% | +$8.97M |
|
|
PARA
32
DELISTED
Paramount Global Class B
PARA
| $180M | 0.97% |
3,265,437
+22,307
| +0.7% | +$1.09M |
|
33
Ally Financial
ALLY
$13.4B
| $177M | 0.95% |
9,428,815
+466,263
| +5% | +$8.03M |
|
34
Western Union
WU
$2.6B
| $175M | 0.95% |
9,085,195
+460,398
| +5% | +$8.28M |
|
35
Tyson Foods
TSN
$20B
| $169M | 0.91% |
2,536,172
+25,790
| +1% | +$1.55M |
|
36
Bread Financial
BFH
$4.19B
| $169M | 0.91% |
961,634
+44,090
| +5% | +$7.7M |
|
37
Jones Lang LaSalle
JLL
$14.8B
| $168M | 0.91% |
1,435,541
+202,613
| +16% | +$24.5M |
|
|
38
Moody's
MCO
$82.5B
| $163M | 0.88% |
1,691,079
-1,924,457
| -53% | -$173M |
|
|
EMC
39
DELISTED
EMC CORPORATION
EMC
| $162M | 0.88% |
6,071,533
-42,687
| -0.7% | -$1.08M |
|
40
Voya Financial
VOYA
$8.78B
| $159M | 0.86% |
5,347,422
+224,661
| +4% | +$6.8M |
|
41
Thermo Fisher Scientific
TMO
$213B
| $159M | 0.86% |
1,122,023
-612,494
| -35% | -$82.1M |
|
|
HES
42
DELISTED
Hess
HES
| $156M | 0.84% |
2,965,528
+133,773
| +5% | +$5.91M |
|
43
Occidental Petroleum
OXY
$57.3B
| $153M | 0.83% |
2,233,482
+79,343
| +4% | +$5.32M |
|
|
44
CME Group
CME
$91.9B
| $151M | 0.82% |
1,569,814
+1,540,731
| +5,298% | +$140M |
|
45
VeriSign
VRSN
$23.8B
| $147M | 0.79% |
1,655,246
+423,210
| +34% | +$34.6M |
|
46
Quest Diagnostics
DGX
$25.1B
| $146M | 0.79% |
2,049,299
+191,893
| +10% | +$12.9M |
|
|
47
Lam Research
LRCX
$400B
| $144M | 0.78% |
+17,431,440
| New | +$127M |
|
48
Hartford Financial Services
HIG
$39B
| $137M | 0.74% |
+2,983,189
| New | +$125M |
|
49
AB InBev
BUD
$155B
| $136M | 0.73% |
1,089,600
-102,700
| -9% | -$12.2M |
|
50
Canadian Imperial Bank of Commerce
CM
$106B
| $135M | 0.73% |
3,589,888
-28,066
| -0.8% | -$935K |
|
Similar funds
AS
LP
Ninety One (UK)'s Q1 2016 Portfolio in Review
As of Q1 2016, Ninety One (UK) held 358 positions worth $18.5B, up 5.5% from $17.5B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Ninety One (UK) deployed $640M of net new capital in Q1 2016, opening 39 new positions and adding to 130 existing holdings. Its largest new stake was Gilead Sciences: 3,051,840 shares worth $280M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Moody's, an estimated $173M trimmed.
- Ninety One (UK)'s largest Q1 2016 buy was Gilead Sciences: 3,051,840 shares worth $280M.
- Ninety One (UK) added most to Alphabet (Google) Class A in Q1 2016, an estimated $218M increase.
- Ninety One (UK)'s biggest Q1 2016 reduction was Moody's, cutting an estimated $173M.
- Ninety One (UK) fully exited Goldman Sachs in Q1 2016, selling an estimated $236M.
- Ninety One (UK)'s ten largest holdings make up 19% of its $18.5B portfolio in Q1 2016.
- Ninety One (UK) opened 39 new positions and closed 55 in Q1 2016.
- Ninety One (UK)'s portfolio value rose 5.5% quarter-over-quarter to $18.5B.
Based on Ninety One (UK)'s 13F filing for Q1 2016, filed 12 May 2016.